Marshall Turner - Xilinx Independent Director
Director
Mr. Marshall C. Turner, Jr., is an Independent Director of Xilinx, Inc. He is chairman of the board of directors of the AB Funds, a 60 billion family of 106 mutual funds. Mr. Turner served as CEO of Dupont Photomasks, Inc., a manufacturer of photomasks for semiconductor chip fabrication between 2003 and 2006, as Chairman from 2003 until the company acquisition in 2005 as well as interim Chairman and CEO in 19992000. In addition, from 2007 to 2014, Mr. Turner served as a member of the board of directors of SunEdison, Inc., a manufacturer of silicon wafers for semiconductor and solar power applications, and solar power plant developer. He also serves on the board of the Smithsonian National Museum of Natural History and the George Lucas Education Foundation. Mr. Turner was involved in the semiconductor and software industries, among others, for 40 years, in a variety of roles including as the CEO of two companies in the semiconductor industry, interim or CEO of three other companies, chairman of two software companies, general partner of an earlystage institutional VC firm, and an early career as an industrial designer and biomedical engineer. From these experiences, Mr. Turner has developed a broad range of skills that contribute to the Board oversight of the operational, financial, and risk management aspects of our business. Mr. Turner has also served on 24 corporate boards of directors and has chaired five of them, giving him meaningful perspective with respect to the various business and governance issues faced by the Board. since 2007.
| Age | 74 |
| Tenure | 17 years |
| Phone | 408 559-7778 |
| Web | www.xilinx.com |
Xilinx Management Efficiency
The company has return on total asset (ROA) of 8.99 % which means that it generated a profit of $8.99 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 27.35 %, meaning that it created $27.35 on every $100 dollars invested by stockholders. Xilinx's management efficiency ratios could be used to measure how well Xilinx manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 1.54 B in liabilities with Debt to Equity (D/E) ratio of 0.45, which is about average as compared to similar companies. Xilinx Inc has a current ratio of 6.67, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Xilinx until it has trouble settling it off, either with new capital or with free cash flow. So, Xilinx's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Xilinx Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Xilinx to invest in growth at high rates of return. When we think about Xilinx's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Martin Madden | Microbot Medical | 57 | |
| Howard Greene | Tandem Diabetes Care | 75 | |
| Gretchen Haggerty | Teleflex Incorporated | 65 | |
| Kathryn McCarthy | SEI Investments | 69 | |
| Kim Foster | Teleflex Incorporated | 68 | |
| Fred Cohen | Tandem Diabetes Care | 60 | |
| Stuart Randle | Teleflex Incorporated | 61 | |
| George Babich | Teleflex Incorporated | 69 | |
| Prattipati Laxminarain | Microbot Medical | 59 | |
| Edward Cahill | Tandem Diabetes Care | 60 | |
| Richard Packer | Teleflex Incorporated | 62 | |
| Richard Valencia | Tandem Diabetes Care | 56 | |
| Carmen Romeo | SEI Investments | 73 | |
| Alexander Whitelam | SEI Investments | N/A | |
| Douglas Roeder | Tandem Diabetes Care | 47 | |
| Yoseph Bornstein | Microbot Medical | 65 | |
| Christopher Twomey | Tandem Diabetes Care | 58 | |
| Andrew Krakauer | Teleflex Incorporated | 66 | |
| Richard Lieb | SEI Investments | 66 | |
| Stephen Klasko | Teleflex Incorporated | 67 | |
| Jesse Treu | Tandem Diabetes Care | 67 | |
Management Performance
| Return On Equity | 27.35 | |||
| Return On Asset | 8.99 |
Xilinx Inc Leadership Team
Elected by the shareholders, the Xilinx's board of directors comprises two types of representatives: Xilinx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xilinx. The board's role is to monitor Xilinx's management team and ensure that shareholders' interests are well served. Xilinx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xilinx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jon Olson, CFO and Executive VP of Fin. | ||
| Elizabeth Vanderslice, Independent Director | ||
| Lorenzo Flores, CFO, Senior Vice President | ||
| Thomas Lee, Independent Director | ||
| Moshe Gavrielov, CEO and President and Director | ||
| Albert Pimentel, Independent Director | ||
| Victor Peng, Executive VP and General Manager of Programmable Products Group | ||
| Vincent Tong, Sr. VP of Global Operations and Quality and Executive Leader of Asia Pacific | ||
| William Howard, Independent Director | ||
| Marshall Turner, Independent Director | ||
| Philip Gianos, Independent Chairman of the Board | ||
| Steven Glaser, Senior Vice President - Corporate Strategy and Marketing | ||
| John Patterson, Independent Director | ||
| Ronald Jankov, Independent Director | ||
| Lori Owen, IR Contact Officer | ||
| Scott HoverSmoot, Senior Vice President General Counsel, Secretary | ||
| Krishnamurthy Rangasayee, Senior Vice President General Manager - Global Sales and Markets | ||
| Saar Gillai, Independent Director | ||
| Mary Krakauer, Independent Director | ||
| Dennis Segers, Independent Director |
Xilinx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xilinx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 27.35 | |||
| Return On Asset | 8.99 | |||
| Profit Margin | 23.06 % | |||
| Operating Margin | 29.58 % | |||
| Current Valuation | 44.11 B | |||
| Shares Outstanding | 247.88 M | |||
| Shares Owned By Insiders | 0.22 % | |||
| Shares Owned By Institutions | 83.54 % | |||
| Number Of Shares Shorted | 10.88 M | |||
| Price To Earning | 60.55 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Xilinx Stock
If you are still planning to invest in Xilinx Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xilinx's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |